Publications by authors named "L Cellai"

Background: Patients, families, the healthcare system, and society as a whole are all significantly impacted by rare diseases (RDs). According to various classifications, there are currently up to 9,000 different rare diseases that have been recognized, and new diseases are discovered every month. Although very few people are affected by each uncommon disease individually, millions of people are thought to be impacted globally when all these conditions are considered.

View Article and Find Full Text PDF

Introduction: Rare diseases (RD) are a health priority worldwide, overall affecting hundreds of millions of people globally. Early and accurate diagnosis is essential to support clinical care but remains challenging in many countries, especially the low- and medium-income ones. Hence, undiagnosed RD (URD) account for a significant portion of the overall RD burden.

View Article and Find Full Text PDF

Caffeine is the most widely consumed psychoactive substance in the world. Strikingly, the molecular pathways engaged by its regular consumption remain unclear. We herein addressed the mechanisms associated with habitual (chronic) caffeine consumption in the mouse hippocampus using untargeted orthogonal omics techniques.

View Article and Find Full Text PDF

Morquio B disease is an attenuated phenotype within the spectrum of beta galactosidase (GLB1) deficiencies. It is characterised by dysostosis multiplex, ligament laxity, mildly coarse facies and heart valve defects due to keratan sulphate accumulation, predominantly in the cartilage. Morquio B patients have normal neurological development, setting them apart from those with the more severe GM1 gangliosidosis.

View Article and Find Full Text PDF
Article Synopsis
  • Lysosomal storage diseases (LSDs), like sialidosis, are rare genetic disorders caused by mutations, such as those in the NEU1 gene, leading to enzyme deficiencies.
  • Sialidosis has two main types; type II shows severe symptoms like intellectual disability, while type I has subtler symptoms, making it harder to diagnose.
  • The study examines five patients with type I sialidosis, discovering new NEU1 mutations and seeking to clarify common initial symptoms to improve diagnoses.
View Article and Find Full Text PDF